Data / Form D filings / Temple Therapeutics Holdings Ltd
Temple Therapeutics Holdings Ltd: Form D filings
Temple Therapeutics Holdings Ltd, a biotechnology company in Geleen, Netherlands, filed 7 Form D notices with the SEC between 2021 and 2023. The latest, on December 26, 2023, reports $25,000 sold of a $5 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- URMONDERBAAN 22, GATE 2, Geleen, Netherlands, 6167
- Phone
- (306) 261-5189
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Cayman Islands
- Year incorporated
- 2020
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1896459
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 26, 2023 | New notice | $5,000,000 | $25,000 | $4,975,000 | 1 | Dec 19, 2023 | sec.gov |
| Dec 26, 2023 | New notice | $3,500,000 | $200,000 | $3,300,000 | 5 | Oct 26, 2023 | sec.gov |
| Dec 26, 2023 | New notice | $3,500,000 | $100,000 | $3,400,000 | 1 | Jun 1, 2023 | sec.gov |
| May 27, 2022 | New notice | $350,000 | $350,000 | 4 | May 5, 2022 | sec.gov | |
| May 27, 2022 | New notice | $600,000 | $600,000 | 3 | Apr 29, 2022 | sec.gov | |
| Jan 3, 2022 | New notice | $10,000,000 | $150,000 | $9,850,000 | 3 | Nov 13, 2021 | sec.gov |
| Dec 9, 2021 | New notice | $1,000,000 | $300,000 | $700,000 | 3 | Oct 20, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Sanj Singh | Executive Officer, Director |
Every Form D from the week of Dec 25, 2023 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Temple Therapeutics Holdings Ltd reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.